Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 51655-921 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 51655 921 52
This is a description of a drug, Atorvastatin Calcium 20mg, containing 30 tablets, with the NDC number 51655-921-52, lot number 39521AX1, and the expiration date of 03/21. It's manufactured by Annnet Company Inc in Philadelphia and distributed by Northwind Pharmaceuticals in Indianapolis. It should be stored at 20C to 25C (68-77F) and kept out of reach of children. The dosage instructions can be found on the package insert. This drug requires a prescription (Rx only).*
Chemical Structure - atorvastatin calcium tablets 1
Figure 1 - atorvastatin calcium tablets 2
The text seems to be presenting data on cumulative incidence in percentage form, with values of 404, 30, and 15. There is also a statistical analysis with HR=0.64 and p=0.0005. The values 20, 25, 30, and 35 likely pertain to the time frame of the data. Therefore, the text appears to be describing the incidence of some event over time and the associated risk analysis.*
Figure 2 - atorvastatin calcium tablets 3
This is a graphical representation of the cumulative hazard percentage for 5 different time points over four years of follow-up. There is also a Hazard Ratio (HR) value of 0.63, a 95% Confidence Interval (0.48-0.83), and a p-value of 0.001. The variables 'T' and '1' are also present.*
Figure 3 - atorvastatin calcium tablets 4
This is a statistical table representing the percentage of subjects who experienced a major cardiovascular event during the study while receiving two different doses of Atorvastatin (10 mg and 80 mg). The data shows that the group receiving Atorvastatin 80 mg had a statistically significant lower risk of experiencing a cardiovascular event compared to the group receiving Atorvastatin 10 mg (HR 0.78 with a confidence interval of 0.69-0.89 and a P-value of 0.0002). Information about the duration of the study and the definition of major cardiovascular endpoint are not provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
